These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 10644338

  • 1. The central proline of an internal viral fusion peptide serves two important roles.
    Delos SE, Gilbert JM, White JM.
    J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
    Delos SE, White JM.
    J Virol; 2000 Oct; 74(20):9738-41. PubMed ID: 11000247
    [Abstract] [Full Text] [Related]

  • 4. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
    Melder DC, Yin X, Delos SE, Federspiel MJ.
    J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
    [Abstract] [Full Text] [Related]

  • 5. Alpharetrovirus envelope-receptor interactions.
    Barnard RJ, Young JA.
    Curr Top Microbiol Immunol; 2003 Sep; 281():107-36. PubMed ID: 12932076
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.
    Balliet JW, Gendron K, Bates P.
    J Virol; 2000 Apr; 74(8):3731-9. PubMed ID: 10729148
    [Abstract] [Full Text] [Related]

  • 7. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
    Delos SE, Burdick MJ, White JM.
    Virology; 2002 Mar 15; 294(2):354-63. PubMed ID: 12009877
    [Abstract] [Full Text] [Related]

  • 8. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
    Delos SE, Godby JA, White JM.
    J Virol; 2005 Mar 15; 79(6):3488-99. PubMed ID: 15731243
    [Abstract] [Full Text] [Related]

  • 9. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
    Ochsenbauer-Jambor C, Delos SE, Accavitti MA, White JM, Hunter E.
    J Virol; 2002 Aug 15; 76(15):7518-27. PubMed ID: 12097564
    [Abstract] [Full Text] [Related]

  • 10. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry.
    Ragheb JA, Anderson WF.
    J Virol; 1994 May 15; 68(5):3220-31. PubMed ID: 8151784
    [Abstract] [Full Text] [Related]

  • 11. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.
    J Virol; 2004 Dec 15; 78(24):13430-9. PubMed ID: 15564453
    [Abstract] [Full Text] [Related]

  • 12. The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.
    Babel AR, Bruce J, Young JA.
    PLoS One; 2007 Jan 24; 2(1):e171. PubMed ID: 17245447
    [Abstract] [Full Text] [Related]

  • 13. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
    Damico R, Rong L, Bates P.
    J Virol; 1999 Apr 24; 73(4):3087-94. PubMed ID: 10074159
    [Abstract] [Full Text] [Related]

  • 14. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
    Zavorotinskaya T, Albritton LM.
    J Virol; 1999 Jul 24; 73(7):5621-9. PubMed ID: 10364311
    [Abstract] [Full Text] [Related]

  • 15. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.
    Yang X, Kurteva S, Ren X, Lee S, Sodroski J.
    J Virol; 2005 Oct 24; 79(19):12132-47. PubMed ID: 16160141
    [Abstract] [Full Text] [Related]

  • 16. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.
    Delos SE, La B, Gilmartin A, White JM.
    J Virol; 2010 Jun 24; 84(11):5687-94. PubMed ID: 20335266
    [Abstract] [Full Text] [Related]

  • 17. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
    Melder DC, Pike GM, VanBrocklin MW, Federspiel MJ.
    J Virol; 2015 Feb 24; 89(4):2136-48. PubMed ID: 25473063
    [Abstract] [Full Text] [Related]

  • 18. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
    Earp LJ, Delos SE, Netter RC, Bates P, White JM.
    J Virol; 2003 Mar 24; 77(5):3058-66. PubMed ID: 12584331
    [Abstract] [Full Text] [Related]

  • 19. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
    Melikyan GB, Barnard RJ, Markosyan RM, Young JA, Cohen FS.
    J Virol; 2004 Apr 24; 78(7):3753-62. PubMed ID: 15016895
    [Abstract] [Full Text] [Related]

  • 20. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K.
    J Virol; 1994 Mar 24; 68(3):1773-81. PubMed ID: 8107239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.